Anthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological Activities

Anthraquinones and their derivatives constitute a large group of quinoid compounds with about 700 molecules described. They are widespread in fungi and their chemical diversity and biological activities recently attracted attention of industries in such fields as pharmaceuticals, clothes dyeing, and food colorants. Their positive and/or negative effect(s) due to the 9,10-anthracenedione structure and its substituents are still not clearly understood and their potential roles or effects on human health are today strongly discussed among scientists. As marine microorganisms recently appeared as producers of an astonishing variety of structurally unique secondary metabolites, they may represent a promising resource for identifying new candidates for therapeutic drugs or daily additives. Within this review, we investigate the present knowledge about the anthraquinones and derivatives listed to date from marine-derived filamentous fungi′s productions. This overview highlights the molecules which have been identified in microorganisms for the first time. The structures and colors of the anthraquinoid compounds come along with the known roles of some molecules in the life of the organisms. Some specific biological activities are also described. This may help to open doors towards innovative natural substances.


Introduction
In recent decades, marine organisms focused the attention of researchers for their huge potential in producing bioactive compounds [1][2][3][4]. Among them, the microorganisms gradually took on an important role because they appear to be prolific producers of a wide diversity of secondary metabolites [5,6]. Cultivated in bioreactors, they also represent a sustainable and easily "upscalable" resource, therefore not endangering fragile marine ecosystems. Among these microorganisms, fungi, which had their terrestrial glory days after the discovery of penicillin, are again at the forefront in the search for new marine molecules in view of their rich biodiversity, even in deep-sea niches [7]. Around 70,000 fungal species have already been described worldwide, and among them about 1500 species of marine-derived fungi were mentioned, primarily from coastal ecosystems [8,9]. As 70% of the earth is submerged, Gareth Jones (1998) [10] estimated the total number of marine and marine-derived fungal species to be a minimum of 72,000, indicating that the inherent discovery of new compounds is still in its infancy. Several fungal metabolites from marine origin have already demonstrated their originality An important characteristic of the anthraquinone compound is their electronic absorption spectra. The strong absorption in the ultraviolet region is due to the presence of chromophore formed by the system of conjugated double bonds. The spectra of anthraquinone are highly complex because of the presence of absorption bands due to the benzenoid transitions, in addition to quinonoid absorptions. The benzenoid bands appear fairly regularly within the range 240-260, with intense absorption at 250 nm and in 320-330 nm, and with medium absorption at 322 nm, whereas the quinonoid bands absorb at 260-290 nm. These areas of selective absorption are characteristic, and the pattern in the ultraviolet region is not seriously affected by substitution. In addition, hydroxyl anthraquinones show an absorption band(s) at 220-240 nm, not shown by the parent compound. In the visible area, an unsubstituted anthraquinone has a weak yellow color, and its electronic absorption spectrum contains a small peak at 405 nm. The presence of substituents in position 1 and 4 induces a significant bathochromic shift, intensifying the color more significantly than the substituents in the 1,5 and 1,8 positions. Thus, with an alcoholic solution of magnesium acetate, 1,2-dioxyderivative is colored in violet; 1,4-dioxyderivative in purple; and 1,8-dioxyderivative in red-orange [28][29][30]. Therefore, fungal anthraquinones range from pale yellow to dark red or brown colors, through to violet.

Ecology of Marine-Derived Fungal Anthraquinones Producers
Marine ecosystems host a wide biodiversity of filamentous fungi found in free waters, inert organic or inorganic matter. They can also be included as endophytes or pathogens in marine plants, planktons, vertebrates and invertebrates [31]. Their different roles in these environments are still poorly known, although their implications in lignocellulolytic compounds degradation and mineralization of organic matter has been repeatedly demonstrated [7,32,33]. Yet the notion of "marine fungus" is still under debate in the world of mycologists. Fungi are usually recognized as ubiquitous because they inhabit a plethora of ecosystems, from terrestrial milieus to aquatic environments ( Figure 2). Marine and marine-derived fungi therefore form an ecological, not a taxonomic, group [34]. From the widely adopted definition of Kohlmeyer et al. (1979) [8], they are divided into two ecotypes:  obligate marine fungi (true ones) that grow and sporulate only in seawater. Their spores are able to germinate and form new thalli in salted environment.  transitional marine fungi (marine-derived fungi) that come from terrestrial or freshwater media and have undergone physiological adaptation to survive, grow, or reproduce in the marine environment. An important characteristic of the anthraquinone compound is their electronic absorption spectra. The strong absorption in the ultraviolet region is due to the presence of chromophore formed by the system of conjugated double bonds. The spectra of anthraquinone are highly complex because of the presence of absorption bands due to the benzenoid transitions, in addition to quinonoid absorptions. The benzenoid bands appear fairly regularly within the range 240-260, with intense absorption at 250 nm and in 320-330 nm, and with medium absorption at 322 nm, whereas the quinonoid bands absorb at 260-290 nm. These areas of selective absorption are characteristic, and the pattern in the ultraviolet region is not seriously affected by substitution. In addition, hydroxyl anthraquinones show an absorption band(s) at 220-240 nm, not shown by the parent compound. In the visible area, an unsubstituted anthraquinone has a weak yellow color, and its electronic absorption spectrum contains a small peak at 405 nm. The presence of substituents in position 1 and 4 induces a significant bathochromic shift, intensifying the color more significantly than the substituents in the 1,5 and 1,8 positions. Thus, with an alcoholic solution of magnesium acetate, 1,2-dioxyderivative is colored in violet; 1,4-dioxyderivative in purple; and 1,8-dioxyderivative in red-orange [28][29][30]. Therefore, fungal anthraquinones range from pale yellow to dark red or brown colors, through to violet. In fungi, anthraquinones are produced from different steps or branches of the polyketides pathway. Today, it is clear that, as far as secondary metabolites and a priori anthraquinoid productions are concerned, a great variability appears among species of the same genus, even among strains in the same species. This could undoubtly be related to the capacities a fungus has to develop, in order to face some specific conditions in specific ecosystems. As an illustration, the composition of the quinoid pigment complexes of P. funiculosum strains isolated from various types of soils are quite different when cultivated in the same artificial culture media [35]. That is why, even if the polyketides pathway is mentioned in a strain, not all strains inside the species are anthraquinones producers. In the same way, if the fungal metabolism is able to express anthtraquinones and (simultaneously) to excrete toxins, the presence of these secondary products are highly dependent on external physico-chemical conditions [36].
Thus, a high diversity of molecules is now expected from unexplored marine-derived fungi, which are considered promising novel sources of chemical diversity. The potential of marine-derived microorganisms to produce unique and original molecules could therefore come from specific metabolic or genetic adaptations appearing to meet very specific combinations of physico-chemical parameters (high osmotic pressure, low O2 penetration, low temperature, limited light access, high pressure, or regular tidal ebbs and flows) [37]. Indeed, the two marine ecotypes lead to particular behaviors and consecutively to specific products, compared to the terrestrial congeners: either the challenge of facing unusual living conditions (exogenous fungi) or the use of specific procedures naturally adapted to the marine niches (i.e., indigenous micromycetes, naturally selected for aquatic environments). This skill is, for instance, exemplified by marine macroorganisms′ fungal endophytes as corals or sponges. For now, the highest diversity of marine-derived fungi seems to be found in tropical regions, mainly in tropical mangroves, which are extensively studied because of their high richness in organic matters. Obviously, these biotopes seem favorable to the development of a high diversity of heterotrophic microorganisms based on the diversity of organic and inorganic substrates [8,38].
The questions on the effect of interactions between organisms on microbes extrolites is amply fueled in the case of a very producive lichen′s symbioses. A lichen is a composite organism that emerges from algae or cyanobacteria (or both) living with filaments of a fungus in a mutually In fungi, anthraquinones are produced from different steps or branches of the polyketides pathway. Today, it is clear that, as far as secondary metabolites and a priori anthraquinoid productions are concerned, a great variability appears among species of the same genus, even among strains in the same species. This could undoubtly be related to the capacities a fungus has to develop, in order to face some specific conditions in specific ecosystems. As an illustration, the composition of the quinoid pigment complexes of P. funiculosum strains isolated from various types of soils are quite different when cultivated in the same artificial culture media [35]. That is why, even if the polyketides pathway is mentioned in a strain, not all strains inside the species are anthraquinones producers. In the same way, if the fungal metabolism is able to express anthtraquinones and (simultaneously) to excrete toxins, the presence of these secondary products are highly dependent on external physico-chemical conditions [36].
Thus, a high diversity of molecules is now expected from unexplored marine-derived fungi, which are considered promising novel sources of chemical diversity. The potential of marine-derived microorganisms to produce unique and original molecules could therefore come from specific metabolic or genetic adaptations appearing to meet very specific combinations of physico-chemical parameters (high osmotic pressure, low O 2 penetration, low temperature, limited light access, high pressure, or regular tidal ebbs and flows) [37]. Indeed, the two marine ecotypes lead to particular behaviors and consecutively to specific products, compared to the terrestrial congeners: either the challenge of facing unusual living conditions (exogenous fungi) or the use of specific procedures naturally adapted to the marine niches (i.e., indigenous micromycetes, naturally selected for aquatic environments). This skill is, for instance, exemplified by marine macroorganisms 1 fungal endophytes as corals or sponges. For now, the highest diversity of marine-derived fungi seems to be found in tropical regions, mainly in tropical mangroves, which are extensively studied because of their high richness in organic matters. Obviously, these biotopes seem favorable to the development of a high diversity of heterotrophic microorganisms based on the diversity of organic and inorganic substrates [8,38].

Endophytes and/or Pathogens
Trichoderma is a frequent genus among vegetal root-associated fungi (endophytes and symbionts).
Several species of Alternaria are terrestrial plants pathogens. Terrestrial Alternaria anthraquinones 1 producers are found in many species, including A. eichorniae, also isolated from marine environments. The main represented compounds in this genus are macrosporin, altersolanol A, and 6-methylxanthopurpurin-3-O-methyl ether. However, original compounds were mainly isolated from marine-derived isolates. Indeed, alterporriols (A, B, C), altersolanol A, austrocortinin, bostrycin, physcion, and macrosporin are excreted by Alternaria species, originating from marine niches. Alterporriols C is commonly found in terrestrial and aquatic strains, but, until now, alterporriol A and B are only ones known from Alternaria 1 s marine-derived strains or from the terrestrial brother-group Stemphylium (S. globuliferum). This similarity in extrolite production with this genus also concerns altersolanol A, produced by several Stemphylium strains, from terrestrial or salted environments (S. botryosum v. lactucum, S. globuliferum).
Stemphylium globuliferum (from Juncus acutus collected from an hypersaline lake in Egypt) generates the common compounds alterporriol D and E, altersolanol A and B, and macrosporin, as well as the genus specific 6-O-methylalaternin [94]. Seven new compounds can also be found in this strain: altersolanol C, dihydroaltersolanol B and C, acetylalterporriols D and E (atropisomers), and stemphylanthranols A and B (the first naturally occurring trimeric anthraquinone derivatives). This endophytic/pathogenic fungus seems very productive in new compounds in marine environments. Indeed, the strain Stemphylium sp. 33231, obtained from the mangrove plant Bruguiera sexangula var. rhynchopetala, excreted four new alterporriol-type anthranoid dimers, along with 17 analogues [93]. In terrestrial habitats, the genus Stemphylium (anamorph of Pleospora) consists of plants pathogens/endophytes. The number of original molecules found in its productions is feeding the idea of originality in compounds coming from plant/microbe associations (alterporriol G and H (atropisomers), altersolanols K and L, as well as the new stemphypyrone) [113].
Fusarium is a widespread plant pathogen. The marine-derived Fusarium strains, mainly associated with marine organisms, produce four completely new anthraquinoid compounds.  [68]. Fusarium spp. PSU-F14 and PSU-F135 (endophytes from the gorgonian sea fan Annella sp., collected in Thailand) excrete the known bostrycin but also austrocortirubin, mainly known from the terrestrial macromycete Cortinarius spp.
Monodictys (from a Japanese sea urchin Anthocidaris crassipina) is producing the common pachybasin, which was found for the first time from this species, along with emodin and chrysophanol, and also the new monodictyquinone A.
Curvularia lunata (anamorphic stage of Cochliobolus lunatus), isolated from the marine sponge Niphates olemda in Indonesia, excretes the new lunatin and cytoskyrin A, a molecule only known from one another species Cytospora sp. CR 200 (endophyte from the buttonwood tree Conocarpus erecta in Costa Rica) [60].
Reviewed by Crous et al. [116], many species of Arthinium are associated with plants as endophytes or parasites, even in marine conditions. Somes strains of Athrinium phaeospermum cause cutaneous infections of humans. Others are involved in endophytic plant relationships, producing growth promoting substances, e.g., in Carex kobomugi. The endophytic Arthrinium phaeospermum CBS 142.55 (type strain of Botryoconis sanguinea) produced bostrycin with some minor unidentified red and yellow pigments when cultured on malt extract agar [117]. Bostrycin is produced by Bostrychonema alpestre, the causal agent of water hyacinth blight disease, as well as by other plant pathogenic fungi such as Alternaria eichorniae, Nigrospora oryzae, Arthrinium phaeospermum and Fusarium spp. Bostrychonema alpestre (terrestrial strains) also excretes austrocortilutein and torosachrysone mainly found in macrofungi as Dermocybe splendida [118].
As far as bostrycin is concerned, the originally proposed structure [119][120][121] was revised by Kelly and his co-workers in 1985 [122] on the basis of the total synthesis of (+/´)-bostrycin and an X-ray crystal structure of the O-isopropylidene derivative. This revision also concerns its derivative 4-deoxybostrycin found in serveral marine isolates [68,84,86,101,123].
A marine-derived strain of Xylaria sp. 2508 produces a new compound, xylanthraquinone, along with three known anthraquinones, altersolanol A, deoxybostrycin, and bostrycin [95]. The Xylariaceae is one of the largest families of endophytic filamentous fungi isolated from plants material in terrestrial biotopes. There, they essentially grow under the form of mycelial structure, and their fruiting bodies (stromata) seem to form only when their host is stressed or diseased. However, the pigments seem to be mainly extracted from their fruiting stages [124]. Under marine conditions the morphological structures of fungi are not yet precisely described, and researchers suppose that fungi are mainly growing under mycelial structures. Nevertheless, this does not prohibit the synthesis of these anthraquinoid molecules.
To date, over 100 different anthraquinoid metabolites have been identified in around 27 marine-derived fungal isolates, belonging to at least 22 identified species.

Biosynthesis and Known Roles for Anthraquinones in Fungi
The metabolism is the sum of all the biochemical reactions carried out by an organism. Opposite to the primary metabolism, converging to few products common to many organisms, the secondary metabolic pathways diverge to a great diversity of molecules produced from a few key intermediates of primary metabolism. While endometabolites can be found in almost all species of fungi, exometabolites seem taxonomically shared by species-specific profiles [132,133]. Some authors then assert that the nature of the extrolites can act as signatures, specific to the organisms, coming from biogenetics patterns. Thereby, in Dermocybe spp., it was possible to group some subsections with regards to biosynthetis of particular anthraquinoid compounds (skyrin, icterinoidin or hypericin) [134]. Considering the significant shortcomings in these research fields, future studies will gain knowledge about the truth of these claims. Undoubtedly subservient to the genetic skills, the biosynthesis of metabolites such as anthraquinone derivatives is clearly influenced and regulated by a complex set of factors including biotic and abiotic dimensions. Such parameters as temperature, pH, [O 2 ] availability, light exposure, nature, and abundance of nutritive sources, as well as age and specialization of the fungal structures, have already been proven to have a strong influence on pigments production [135][136][137][138][139].

Biosynthetic Route and Genes Involved
As polyketides seem to be the most abundant extrolites in fungi, the pathways for their biosynthesis have been widely explored [140]. However, the formation of anthraquinones in fungi is not the most developed area in the literature.
In fungi polyketide compounds are primarily synthesized by the acetate-malonate pathway (Figure 3), which is different from plants using shikimate pathways as well as acetate-malonate metabolism. Depending on the presence of acetate, malonate, or both components, according to the growth conditions, and to the strains involved, the numbers of each residue incorporated differ, and the final secondary metabolites as well. The involvement of each type of molecule can be studied through experiments using [ 13´14 C-acetate] and [ 13´14 C-malonate], ( [141] and other authors such as Gessler et al. [17]. In relation to this acetate-malonate pathway, the biosynthetic relationships seem to form yellow hydroxyanthraquinones (e.g., emodin, physcion, and dermolutein) at the beginning of the pathway (simple structures), whereas the red ones, such as dermorubin or dermocybin, with more complex structures, certainly occur in the latter part of the biosynthesis pathway [16].
Hanson et al. [15] and Gessler et al. [17] summarized that anthraquinones synthesis are regulated by non-reducing polyketide synthases (NR-PKS 1 s). These multidomains enzymes mediate the regioselective cyclization of polyketides, clearly dominating the final structures. NR-PKS 1 s form polyketides in which carbonyl groups are not reduced, whereas reducing polyketide synthases partially or fully reduces the carbonyl groups [142,143]. These multifunction complexes, including acyl carrier protein (ACP), transacylase (STA), ketosynthase (KS), malonyl-CoA transacylase (MTA), thioesterase (TE), product template (PT) domain, methyltransferases, and reductases, first ensure the condensation of acetyl-CoA (starter unit) and malonyl-CoA (extender unit). This produces an instable β-polyketide chain (containing a free carboxylate group) precursor of different aromatic structures. There are several types of PKSs found in different organisms (groups I-VIII), but the principles of constructing the poly-β-keto chain are the same with all PKSs.   From these, the fungal PKS are of considerable interest due to their interesting enzymology and the final polyketide structural diversity [144]. One of the earlier major advances in identification of fungal polyketide secondary metabolite gene clusters is the development of a degenerate-primed polymerase chain reaction (PCR), based on the conserved ketosynthase domain of PKS [145]. Javidpour et al. [146] asserted that the specific enzyme product template (PT) domain, determined the regioselectivity of the cyclization of the polyketide chain, and then the final structure of the products. Thus, they appeared as key factors in the biodiversity of these secondary metabolites. In fungi PT, domains are found in all 8 groups, but anthraquinoid compounds seem to be mainly produced from PT IV and V groups, indicating C4-C9 or C6-C11 cyclizations.
Based on a bioinformatical analysis, Liu et al. [147] interestingly clarified the relationships between enzyme sequences, structures, and functions in fungal PKS PT domains. Besides the basic PKS domain, additional functional domains, including the SAT (starter unit-ACP transacylase) domain, the PT (product template) domain, and the TE (thioesterase) releasing domain, are unique to the NR-PKSs. The PT domains have been demonstrated to be involved in controlling specific aldol cyclization and aromatization of the polyketide precursors. For the first cyclization, three commonly cyclizing patterns appear (C2-C7, C4-C9, and C6-C11). The comparison of 661 NR-PKS sequences belonging to ascomycota and basidimycota revealed that the PT domains can be classified into prominent eight groups (I-VIII) corresponding with the representative compounds and the cyclization regioselectivity. Most of the cavity lining residue (CLR) sites were common in all groups, while the regional CLR site mutations resulted in the appearance of finger-like regions with different orientation. The conservative residues in PT sequences were responsible for the cyclization functions and the evolution of the key residues resulted in the differentiations of cyclization functions. Thus, the cavity volumes and shapes, even the catalytic dyad positions of PT domains in different groups, corresponded to characteristic cyclization regioselectivity and compound sizes.
These authors also noticed that the cyclization route of the polyketide chains even differ between actinomycetes and fungi, certainly due to the involvment of different groups of PT enzymes [148]). Moreover, the late steps of the biosynthesis are responsible for the additions and deletions of lateral substituent groups, generating a great diversity of compounds. For instance, they assert that methyl groups of anthraquinones come from methionine residues via S-adenosylmethionine [149][150][151][152][153].
Miethbauer et al. [141] tried to elucidate the biosynthetic pathway of a complex anthraquinone via the synthesis of rubellins. Nineteen species of Ramullaria coming from different regions were tested for the production of rubellins A, B, C, D, E, and F. Seventeen biosynthesized the entire panel of rubellins, more or less intensively, except two of them: R. pratensis and R. inaequalis. They stated that, using [ 13 C-acetate], rubellins are naturally synthesized through the polyketide pathway. They demonstrated that the methyl group of acetate must be converted in part to a carboxyl one via protein turnover, or more specifically by biosynthesis, and the subsequent degradation of lysine in fungi [154]. They suggested that rubellin A and B are certainly originating from a dimeric anthraquinone and that helminthosporin (1,5,8-trihydroxy-3-methylanthraquinone) can be considered the primordial monomer. The conversion of the keto group into a lactone is supposed to be carried out by a Baeyer-Villiger monooxygenase [155]. Thus, they proved that, if the majority of the strains can use these rubellins as nonspecific toxins against plants, some of the species are, surprisingly, completely unable to produce such molecules.
The recent whole-genome sequencing of various fungi revealed that these microorganisms have immense biosynthetic potential, surpassing, by far, the chemical diversity observed in laboratory cultures. For example, the genome of many Aspergilli encodes a combined 30 to 80 PKS-non-ribosomal peptide synthetases and polyketide non-ribosomal peptide synthetases hybrids-which far exceed the total number of known polyketides and non-ribosomal peptides [156].
Recently, Bringmann et al. [157] revealed that the pigment chrysophanol can come from an organism-specific route, through a third folding mode involving a remarkable cyclization of a bicyclic diketo precursor. This establishes the first example of multiple convergences in polyketide biosynthesis.
The programming of the fungal PKS seems quite complex and suitable to form sophisticated products. An additional level of complexity can be imagined combinatorializing PKS-based pathways with other metabolic routes.
Kakule et al. [158] realized a gene fusions with the idea of testing the connection and compatibility of the PKS and NRPS (nonribosomal peptide synthetase) modules, mediated by the ACP, condensation (C) and ketoreductase (KR) domains. The resulting recombinant gene fusions availed six new compounds. They obtained the first successful fusion between a PKS and NRPS that make highly divergent products as well as previously reported molecules. Thus, they demonstrated that, within the highly reducing (hr) PKS class, noncognate ACPs of closely related members can complement PKS function.
Today, it is rather clear that many of the genes involved in the polyketide pathway are organized in gene clusters, which are often silent or barely expressed under laboratory conditions. This makes their study more difficult. Fortunately, the genome sequences of several filamentous fungi are now publicly available, greatly facilitating the establishment of links between genes and metabolites. To date, complete knowledge about the biosynthetic pathway of hydroxyanthraquinonoid compounds is not yet available, but this knowledge is increasing daily.

Roles in the Biology of Fungi
Anthraquinones belong to secondary metabolites. The secondary metabolic pathways are today considered as diversions from the primary metabolism, leading to a great diversity of compounds, arising from a few key intermediates. Secondary metabolites, also known as exometabolites, are produced during morphological and chemical differentiation, either accumulated or excreted. In contrast, endometabolites (primary metabolites) fluctuate in concentrations and either transform into other endometabolites or feed into exometabolites. Secondary metabolites are bound to appear when the environmental conditions become unfavorable, in particular when a substrate other than carbon becomes limited [159]. This process of derivation is important in itself. Indeed it is supposed to provide a route for the removal of intermediates, which would otherwise accumulate. This accumulation could probably enable the primary processes leading to these intermediates to remain operational during the time of stress [160]. For researchers, this formerly implied two main features: (1) Cells that are no longer undergoing balanced growth synthesize them for a finite period; and (2) no obvious functions were clearly demonstrated in cell growth for these compounds. Thus, they appeared to researchers to be not vital to the cell life itself. Nowadays, the trend is, through their direct or indirect actions, secondary metabolites are important for the entire organism 1 s survival [161][162][163]. Due to their chemical and biological properties they are today considered as first-plan actors to help in protection, competition, symbiosis, metal transport, differentiation, etc. The biological significance of anthraquinoids pigments, as others such as carotenoids, involves resistance to a variety of adverse environmental factors (dessication, exposure at extreme temperatures, irradiations), to antimicrobial activity (antibacterial, antiviral). Many observations have now been published with regard to the antioxidant activity of carotenoids pigments, protective action against lethal photooxydation, inhibition of mutagenesis, enhancement of the immune response, and inhibition of tumor development [164]. Melanin was also suggested to act as a shield against immunologically active cells [165].
Besides the intensively investigated fungal azaphilone pigments, anthraquinone compounds have been considered among the most abundant fungal natural products, giving color to spores, sclerotia, sexual bodies, and other developmental structures [139]. Present research suggests that, in specific cases, it is doubtful that pigments are really secondary metabolites [164]. It is now clear that anthraquinones should play a role in the cell life.

Anti-Oxidant/Pro-oxidant Activities
Solar radiations contain stress factors for living organisms, especially UV-B. Thus, the biological role of pigments, as the dark brown to black melanin and melanin-like pigments, often restricted to certain developmental stages or special structures (chlamydospores or microsclerotia), is clearly dedicated to growth, dissemination, and survival under unfavorable conditions. The accumulation of pigment acts as a radiation-screening system that prevents the occurence of damages. It is clear that, in unusual biotopes (sometimes extreme), the fungal species with pigmented cell walls (in the sexual stages, conidia, and/or mycelium) are able to tolerate dehydration-hydration cycles or high solar radiations better than the moniliaceous fungi, whose cells are devoid of pigments. These aromatic compounds, such as melanin, sporopollenin (brown product of oxidative polymerization of β-carotene) and cycloleucomelone (terphenylquinone) [18], often show significant antioxidant activities and are bound to protect the biological structures, giving them an excellent durability and a high potential for survival in hostile environments. However, at higher doses or under certain conditions, antioxidant-type functional compounds may exert toxic pro-oxidant activities, as was demonstrated in vitro for vitamin C, E, carotenoids or flavonoids [166]. This is not a new idea, as Paracelsus (1493-1541) already reported toxicity to be a matter of dose. Thus, toxicological risks may arise when daily doses of a compound rise above a certain threshold limit.
Things are not so clear about the relationships between carcinogenic effect and pro-oxidant properties. Indeed, pro-oxidant natural products inducing ROS (reactive oxygen species) were proved to contribute to anticancer effects as for campothecin derivatives [167]. Pro-oxidant natural products then become an attractive anticancer strategy.
Identically, quinonoid structures allow anthraquinones to participate in redox reactions, exhibiting antioxidant or pro-oxidant properties. Emodin and physcion have clearly demonstrated antioxidant and antimicrobial activities [168]. According to Yen et al. [169], the basic anthrone chemical structure exhibited the role of electron acceptor, and the ortho-dihydroxy substituent in alizarin, the polyhydroxyl group at position C1, C6 and C8 with methylation at position C3 (emodin), and the polyhydroxyl group at position C1 and C8 with hydroxylmethylation at position C3 (aloe-emodin), are multifunctional antioxidants, combining both chain-breaking and metal-chelating properties. Moreover, they stated that the greater reducing power and the metal chelating activity of alizarin may relate to its marked antioxidant activity. On the other hand, the significant scavenging effect of emodin and aloe-emodin on hydroxyl radicals may contribute to their antioxidant activity. Alaternin also inhibited the peroxidation of linoleic acid by the thiocyanate method in a dose-dependent manner, and showed inhibitory activities in reactive oxygen-and nitrogen-mediated reactions, indicating that it is a potentially effective and versatile antioxidant useful, for protecting biological systems and functions against various oxidative stresses [170]. On the other hand, chrysophanol accelerated the peroxidation of linoleic acid.
Another illustration is the symbiotic foliose lichen Xanthoria parietina, which is able to colonize very extreme environments. The cortical anthraquinoid pigment parietin (physcion) is mainly synthesized by the mycobionte and absorbs UV-B and part of PAR (photosynthetically active radiations). Its production depends on several factors. The UV-B induction (280-320nm) and the photosynthetic assimilation of carbon in the photobionte, the green algae Trebouxia arboricola, increases the production of parietin; the lack of PAR, dessication, or substancial depression decreases the production [171,172]. Conversely, in artificial culture conditions, it seems that light in the visible part of the spectrum significantly decreases the pigment production in Isaria farinosa, E. nidulans, F. verticilloides, and P. purpurogenum [173].
There is therefore a strong correlation between the anthraquinoid contents and site factors, including the openness of the habitat, suggesting that solar radiation plays a crucial role.

Competition and Symbiosis
Endophytic/symbiotic associations may clearly involve some complex regulation mechanisms. Cases of interspecific regulations are already recorded concerning anthraquinones. In vitro, anthraquinones production in Aspergillus kanagawaensis is, for instance, stimulated by co-cultures with different species [174]. The study also proved that a hydroxyanthraquinone molecule was able to stimulate the synthesis of exoproteases, in Aspergillus kanagawaensis cultures alone and during co-culture with A. wentii.
Trichoderma is a frequent genus among vegetal roots associated fungi (endophytes, symbionts) [175]. By colonizing the surface of pinaceae roots, Trichoderma viride, for instance, is supposed to confer physiological benefits to the seedlings, enhancing the plant-soil exchanges and probably exerting a photoprotective activity [176]. From this review, this genus is also mentioned to suppress fungal disease in plants and soils, and also to promote plant growth [177]. The frequent antimicrobial activity of anthraquinones clearly enhances the host plant resistance against pathogens (bacteria, fungi). This led, for instance, to a patent describing a plant protection product, using a formulated Polygonaceae extract (Reynoutria sachalinensis) marketed as REGALIA ® SC by Marrone Bio Innovations, Inc. (Davis, CA, USA) [178]. The MBI-106 active principle contains at least physcion, emodin, chrysophanol, ventiloquinone, emodin glycoside, chrysophanol glycoside, physcion-glycoside, 3,4-dihydroxy-1-methoxyanthraquinone-2-corboxaldehyde, and damnacanthal. The results support a general hypothesis that the presence of the functional metabolites of endophytes enhances the host plant fitness and competitivness in stressful environments [179]. Moreover, they certainly play an important part in inter-or intra-specific competions, combating other microbes in natural micro-environments.
From a functional point of view, in the review of Gessler [17], catenarin and emodin were able to inhibit the DNA-dependant RNA-polymerase of E. coli. In Trichoderma, the increase in excreted emodin or pachybasin concentrations increases the concentration of cAMP, indicating that these compounds are key substances in the regulation of this secondary messenger and thereby in intracellular signaling. Alterporriol-type dimers from S. globuliferum and altersolanol from the endophytic Ampelomyces sp., as well as many other anthraquinones, are able to inhibit several protein kinases, playing significant roles in host cells proliferation (PKC-e, CDK4, EGF, etc.). The anticancer properties of some anthraquinones can also be partially explained through the inhibition of the Cdc25 phosphatase, demonstrated for emodin, questin, and physcion, as well as through the capacity to activate the capsase's cascade, inducing apoptosis of tumor cells.
The vast array of metabolites produced by microbes in their growth environments undoubtedly has an ecological role in regulating the interactions between plants, microorganisms, insects, and animals. Highlighting these facts, we should ask ourselves about the high capacity of endophytes or symbionts to synthesize original molecules arising from the interactions with their host organisms. Many questions then arise about the contribution of partners in such associations, especially concerning anthraquinoid compounds.

Chelating Properties
Greenaway et al. [180] proved that the red anthraquinoid pigment from Pyrenophora avenae (1,4,5,8-tetrahydroxyanthraquinone) removed phenyl-Hg + ions (Phenyl Mercuric Acetate (PMA)) from an aqueous solution. They stated that strains secreting a visible amount of the pigment were invariably resistant to PMA, and those lacking the pigmentation were susceptible. They noticed that resistance to PMA and pigment production were linked in the segregation of resistant and susceptible progeny of conidiospore from a resistant colony. They concluded that the chelation of the Hg ions by the anthraquinone molecule produces a stable and non-toxigenic complex, protecting the cells proteins from binding with toxic mercury through their sulfhydryl groups. This demonstrated the detoxification potential of anthraquinoid pigments in strain metabolism. However, they demonstrated that pigment-producing strains grew more slowly than unpigmented ones in media lacking PMA. They suggested that an unsaturated chelator produced by resistant strains could act to their detriment by chelating substances required for growth. Several articles refer to the metal-chelating properties of anthraquinoid compounds in vitro (such as copper and palladium [181]). These favorable chelating properties towards toxic ions such as aluminium were also demonstrated in plants by studying the impact of soil anthraquinones on the growth of Alfalfa and lettuces [182]. However, they stated that the chelating properties were depending on the structure: Some anthraquinones presented an inactive form (glycoside form), while others demonstrated effective chelating properties (mainly monomeric: physcion, emodin, and chrysotalunin).

In Vitro Biological Activities of Natural Anthraquinones from Marine-Derived Filamentous Fungi
In recent years, marine microorganisms are increasingly attracting attention of the pharmaceutical community as they produce a wide variety of secondary metabolites that are structurally unique and pharmacologically active [104]. Naturally occurring anthraquinones have been recognized to possess anti-inflammatory, anti-fibrotic, and antitumor properties and thus are applied in human and veterinary therapeutics as active substances of medicinal products. Huang et al. [183] demonstrated that anthraquinones isolated from plants, such as emodin, aloe-emodin, and rhein, inhibit the growth and proliferation of various cancer cells, such as lung adenocarcinoma, myelogenous leukemia, neuroblastoma, hepatocellular carcinoma, bladder cancer, and others. The chemical diversity and biological activities of fungal anthraquinone and derivatives from marine origin are considerable; thus, they may represent a promising resource for identifying new therapeutic drugs candidates [184].

Antitumor Activity and Cytotoxicity
Cancer has become an increasing public health problem due to its high rates of morbidity and mortality. Conventional cancer chemotherapy has the limitation of multidrug resistance caused by an overexpression of integral membrane transporters, which can efflux intracellular anticancer drugs, thus decreasing drug accumulation. Clinical multidrug-resistant (MDR) cells are resistant to cytotoxic effects of various structurally and mechanistically unrelated chemotherapeutic agents. Developing new anticancer drugs that are efficient to MDR cells is a feasible strategy to overcome MDR. In the discovery of new fungal anthraquinone-derivative therapeutic molecules, cytotoxic activity is one of the prominent assays to develop novel anticancer drug candidates [184].
Cancer development largely results from uncontrolled growth of malignant cells in which cell proliferation surpasses cell death. Deregulation of apoptosis, occurring in a majority of cancer types, has since become a non-negligible target for anticancer strategies. Pro-apoptotic compounds derived from marine sources, are thus under active investigation for their therapeutic effects, and for their mode of actions against various cancers as well [104].
Apoptotic cells are usually characterized by several distinctive morphological and biochemical changes, including cell shrinkage, chromatin condensation, presence of phosphatidylserine on cell membrane surface, DNA fragmentation, protein cleavage at specific locations, and increased mitochondrial membrane permeability. A cascade of caspases activation in an ordered and regulated manner is also known to be involved in apotosis as a suicidal process [104].

Breaking the Cell Cycle/Apoptosis Hallmarks
Norsolorinic acid, a fungal anthraquinone derivative originally isolated from the fungus Aspergillus nidulans, was investigated for its anti-proliferative activity in human breast adenocarcinoma MCF-7 cells by Wang et al. [185]. The results showed that it induced apoptosis of MCF-7 cells.
Using the yeast Saccharomyces cerevisiae as a model, Xu et al. [103] showed that bostrycin inhibits cell proliferation by blocking the cell cycle at G1 phase. Bostrycin-induced lethal cytotoxicity is actually accompanied with increased levels of intracellular reactive oxygen species and hallmarks of apoptosis such as chromatin condensation, DNA fragmentation, and externalization of phosphatidylserine. This compound also decreases mitochondrial membrane electric potential and causes mitochondrial destruction during the progression of cell death. In this case, apoptosis appears as a mitochondria-mediated but caspase-independent pathway.
In 2011, Ren et al. [186] reported the isolation of nidurufin, a hydroxy derivative of averufin, from the marine-derived fungus Penicillium flavidorsum SHK1-27. An evaluation of the antitumor activity indicated that nidurufin induced in vitro cell cycle arrest at G2/M transition in the leukemia K562 cell line, in a concentration and time-dependent manner, with an IC 50 value of 12.6 µM.
Research findings on emodin-induced cytotoxicity and its protective effects against cancer in different body systems, as well as the antitumor mechanisms involved, are well documented in the literature, though still in progress. This compound (1,3,8-trihydroxy-6-methyl-anthraquinone) is reported to have multiple biological activities including antimicrobial, antiviral, anti-inflammatory, anti-ulcerogenic, immunosuppressive, chemo-preventive, and antitumor functions on digestive, respiratory, reproductive, and blood system cancers. It was first assigned to be a specific inhibitor of the protein tyrosine kinase p65lck. Its inhibitory effect on mammalian cell cycle modulation studied in specific oncogene overexpressed cells formed the basis of using this compound as an anticancer agent [187].
Recently, quinofuracins A-E, novel anthraquinone derivatives containing β-D-galactofuranose that were isolated from the fungus Staphylotrichum boninense PF1444, also induced p53-dependent cell death in human glioblastoma LNZTA3 cells [188] Other pharmaceutical studies have shown that emodin may induce apoptosis but also reverse multidrug resistance in HL-60 and HL-60/ADR cells. It may improve the expression of globin genes in leukemia K562 cells. It also induces K562 cells to erythroid differentiation, possibly via upregulating ALAS2 and c-KIT, and downregulating miR-221 and miR-222 [189]. Furthermore, Chen et al. [190] reported that emodin exhibited significant anti-leukemic effects in vitro. Increasing a dose of emodin could effectively induce growth inhibition and apoptotic effects in NB4 and MR2 cell lines, as well as in primary leukemic cells from acute myeloid leukemia (AML) patients in a dose-dependent manner. This clonal hematopoietic stem cell disorder is characterized by differentiation arrest, inappropriate proliferation, and survival of immature myeloid progenitors. Importantly, emodin was demonstrated as a new inhibitor of phosphatidylinositol 3-kinase (PI3K)/Akt in AML cells. Indeed, cell death and survival are under modulation of a network of transmembrane and/or intracellular signals in which the PI3K/Akt pathway is a prominent mediator of the survival and the proliferation. PI3K/Akt signaling pathway is frequently activated in AML cells and in other malignant phenotypes in a wide variety of cancers. Akt 1 s phosphorylation occurs in response to PI3K activation. Thus, the interruption of the PI3K/Akt signaling pathway should be considered when designing anti-AML therapeutic strategies [190]. Emodin inhibited Akt phosphorylation (p-Akt) at Ser473 as efficiently as mTOR at Ser2448. Consistently, it exerted suppression effects on the phosphorylation of mTOR downstream targets, i.e., 4E-BP1 and p70S6K. Therefore, they provided a demonstration that nontoxic dose of emodin inhibited growth and induced differentiation to a low degree in NB4 and MR2 cells. Moreover, the apoptotic induction in AML cells was associated with the activation of caspase cascades, involving caspase-9, caspase-3, and poly(ADP-ribose) polymerase cleavage. Taken together, these findings indicate that emodin might be considered a promising anti-leukemic agent to overcome all-trans retinoic acid-resistance and to improve the patient outcome in AML.
In this topic, previous studies reported the isolation of five anthraquinone derivatives from the marine endophytic fungus Halorosellinia sp. No. 1403 [70]. One of these compounds, e.g., the marine anthraquinone called SZ-685C showed strong cytotoxicity toward KB and KBv200 cancer cell lines, with IC 50 values of 1.40 and 2.58 µg/mL, respectively [70]. This compound inhibits the growth of six tumor cell lines, including human glioma, hepatoma, prostate cancer, MCF-7, and MDA-MB-435 breast cancer cell lines, with IC 50 < 10 µM [104]. Furthermore, in vivo experiments showed that SZ-685C inhibits the tumor growth in nude mice by inducing apoptosis via the Akt/forkhead box protein pathway [104]. Subsequently, Zhu et al. [106] found that this marine anthraquinone derivative causes apoptosis in adriamycin-resistant human breast cancer cells, both in vitro and in vivo. It exerts these antitumor effects through multiple mechanisms mainly involving the suppression of Akt signaling. More recently, Chen et al. [191] reported that SZ-685C significantly inhibited the proliferation of MMQ pituitary adenoma cells and induced apoptosis by downregulation of miR-200c. In addition, this compound showed potent anticancer activity in radiosensitive and radioresistant nasopharyngeal carcinoma cells, and the miR-205-PTEN-Akt pathway is the mechanism underlying the anticancer activity [192].

Capsase Dependant Pathway Disturbance/Topoisomerase Inhibition
In 2013, Teiten et al. [193] reported that altersolanol A, a natural anthraquinone derivative originally isolated from the endophytic fungus Stemphylium globuliferum, showed cytotoxic, cytostatic, anti-inflammatory, and anti-migrative activity against human cancer cell lines (chronic myeloid K562 leukemia and A549 lung cancer cells) in a dose-dependent manner. Interestingly, this compound did not affect the viability of non-cancerous cells. Results clearly demonstrated that altersolanol A induces cell death by apoptosis through the cleavage of caspase-3 and -9, and through the decrease of antiapoptotic protein expression. Acetylation of altersolanol A did not improve activity, whereas other altersolanol derivatives such as tetrahydroaltersolanol B and ampelanol (one of the carbonyl group reduced and some hydroxyl substituents removed) were inactive in comparison.
More recently, a novel anthraquinone derivative with a complex skeleton, naphtho[1,2,3-de]chromene-2,7-dione skeleton, identified as aspergiolide A, was isolated from the marine-derived fungus Aspergillus glaucus [194]. The compound exhibited distinct cytotoxicities against cancer cell lines A-549, HL-60, BEL-7402, and P388. It was demonstrated that aspergiolide A had anticancer activity targeting topoisomerase II. It clearly decreased the growth of various human cancer cells in vitro and induced apoptosis in BEL-7402 cells via a caspase-dependent pathway. In vivo, aspergiolide A exhibited significant anticancer activity on the growth of hepatocellular carcinoma xenografts. The maximal tolerable dose of aspergiolide A was more than 400 mg/kg, and it was not considered to be potentially genotoxic or cardiotoxic.
Finally, the marine anthraquinone compound called G503 was isolated in 2014 from the secondary metabolites of the mangrove endophytic fungus Halorosellinia sp. No. 1403. This anthraquinone derivative was reported to have antitumor activity [195]. The experiments suggested that the intrinsic mitochondrial apoptosis pathway was also involved in G503-induced apoptosis. The endoplasmic reticulum apoptosis pathway might also be activated by G503 by inducing capase-4 cleavage. In consideration of this inhibition effect on gastric cancer cells, the marine anthraquinone derivative G503 may serve as a promising candidate for gastric cancer chemotherapy.

Cytosolic free Calcium Flux Modification/Reactive Oxygen (ROS) Formation/Mitochondria Dependant Apoptosis
Huang et al. [49] isolated three new bianthraquinone derivatives, alterporriol K, L, and M, from the endophytic mangrove fungus Alternaria sp. ZJ9-6B. Of these three derivatives, alterporriol K and L were moderately active against MDA-MB-435 and MCF-7 human breast cancer cell lines (IC 50 values of 13.1-29.1 µM) [49]. Moreover, alterporriol L could induce cancer cell apoptosis or necrosis. Furthermore, the reactive oxygen species production, mitochondrial membrane potential, and cytosolic free calcium level were changed after treatment with alterporriol L, suggesting that alterporriol L played vital roles in breast cancer cells, through destroying the mitochondria [196]. The bianthraquinone derivative alterporriol F was previously isolated from the pathogenic fungus Alternaria porri. This compound was found to be highly cytotoxic towards HeLa and KB cells, with IC 50 values of 6.5 and 7.0 µM [197].
Recently, Hu et al. [198] reported that rhein could inhibit the purinergic P2X 7 receptor-mediated rat peritoneal macrophages responses, such as increases in the intracellular cytosolic calcium concentration, pore formation, reactive oxygen species production, attenuation of phagocytosis, and cell apoptosis. P2X 7 receptor plays important roles in inflammation and immunity. Thus, rhein can be considered as a potential antagonist of the purinergic P2X 7 receptor, which is a potential therapeutic target for inflammatory diseases.

Transport Inhibition/Synergic Ffects
In 1994, the compound 3,9-dihydroxy-1-methoxy-7-methyl-anthraquinone, identified as the antibiotic C3368-B produced by the fungus strain, Chrysosporium verrucosum Tubaki, was found to be a highly-active nucleoside transport inhibitor. This fungal anthraquinone derivative was shown to markedly inhibit thymidine and uridine transport in Ehrlich carcinoma cells, with the half-maximal inhibitory concentration (IC 50 ) values of 7.5 and 9.6 µM, respectively. It showed fairly low cytotoxicity towards tumor cells. The IC 50 values for epidermoid cancer KB cell lines and hepatoma BEL-7402 cells in clonogenic assays were 77 and 69 µM, respectively. At relatively non-cytotoxic concentrations, it markedly enhanced the cytotoxicity of methotrexate, 5-fluorouracil and mitomycin C against KB cells and BEL-7402 cells. It was also found to partly reverse the multi-drug resistance to vincristine and actinomycin D in mouse leukemia L1210/MDR cells. The IC 50 values were reduced by 4.9-fold (1.75 to 0.36 µM) for vincristine and 3.3-fold (0.39 to 0.12 µM) for actinomycin D. The results suggest that this anthraquinone derivative may be potentially useful in cancer chemotherapy [199].
At present, the role of emodin in combination chemotherapy with standard drugs, in order to reduce toxicity and to enhance efficacy, is pursued vigorously [200]. For example, the synergic effect of arsenic trioxide (currently used to treat acute promyelocytic leukemia), with emodin in combination with clinically achievable doses of docosahexaenoic acid, reduced arsenic concentrations by 100-fold, while still remaining highly toxic to tumor cells [201]. It was also displayed that emodin enhanced the activity of gemcitabine against pancreatic cancer in mice by promoting the mitochondrial-dependent apoptotic pathway. Gemcitabine is currently the standard first-line chemotherapeutic agent for pancreatic cancer [202].

Regulation of Fibrotic and Tumorigenic Mediators
In a way similar to emodin, clinical studies and experiments with animal disease models or different functional cells demonstrated that the anthraquinone rhein (4,5-dihydroxyanthraquinone-2-carboxylic acid) exerted multiple functions including anti-carcinogenesis, antioxidant, anti-inflammation and immunosuppression [198]. For instance, its application notably suppressed the mRNA and protein levels of various fibrotic and tumorigenic mediators, including alpha-smooth muscle actin, type I collagen, fibronectin, N-cadherin, and matrix metalloproteinases in several mammalian cells (rat pancreatic stellate cells, human pancreatic ductal adenocarcinoma cells, and human colon carcinoma cells SW480 and SW620) [203].

Limitation of Vascularization
Recently, the effect of emodin on the growth of transplanted U14 cervical cancer cells in mice and its antitumor mechanism were reported by Zhang et al. [204]. Emodin might suppress the growth of cervical cancer by reducing tumor neovascularization, decreasing macrophage 1 s migration inhibitory factor expression and promoting tumor cell apoptosis. The tumor inhibition rates were 15.83%, 46.92%, and 51.22% in the low-dose emodin group (20 mg/kg), high-dose emodin group (40 mg/kg), and cisplatin group (3 mg/kg), respectively. The tumor inhibition rates were higher in the latter two groups than that in low-dose emodin group. It was also revealed that emodin attenuated tumor cell-induced metastasis and angiogenesis, both in vitro and in vivo [205]. Finally, emodin has been reported to inhibit the growth of pancreatic cancer PANC-1 cells, which may be related to the demethylation of tumor suppressor genes. The related mechanism may be through the inhibition of methyltransferase expression [206]. Consequently, these results provide important insights into emodin as an anti-invasive agent, for the therapy of human pancreatic cancer at least.

Induction of DNA Damages
Two furofuran precursors of sterigmatocystin, versicolorin A and versicolorin B (i.e., two anthraquinone derivatives), were identified in the culture of the fungus Aspergillus versicolor [207]. In a cytotoxicity study of these molecules on human adenocarcinoma lung cells A549, the IC 50 values in the MTT assay (3-(4,5-dimethyl-2-thiazolyl)2,5-diphenyl-2H-tetrazolium bromide cell proliferation assay) were as follows: 109 µM for versicolorin A and 172 µM for versicolorin B. The two compounds were found to exert significant DNA damages, compared to the control in the comet assay. Versicolorin B produced the highest DNA damages [207].

Hydroxy Groups and Hydrogen Bonding between Biomacromolecules
In 2010, Zhang et al. [184] reported the isolation of fourteen hydroxyanthraquinone derivatives from the mangrove fungi Guignardia sp. No. 4382 and Halorosellinia sp. No. 1403. Some of these hydroxyanthraquinones showed potent cytotoxicity to drug-sensitive parental KB and KBv200 cancer cell lines. Among them, one monohydroxyanthraquinone-1-hydroxy-3-methyl-anthraquinone-displayed strong cytotoxicity with IC 50 values of 3.17 and 3.21 µM to KB and KBv200 cancer cell lines, respectively (MTT assay). The authors suggested that various substituting groups modulated the different contributions of these natural hydroxyanthraquinones towards the anticancer activity. It is believed that hydroxy groups perform important roles by offering hydrogen bonding with biomacromolecules such as proteins. At the same time, the quantity and location of hydroxy groups are fundamental to the activities of the anthraquinone compounds [208]. The compound 1-hydroxy-3-methylanthraquinone, containing only one hydroxy group on position R1, showed the most potent inhibition of growth of KB cells and KBv200 cells. Interestingly, dihydroxyanthraquinones with 1-hydroxy and another hydroxy on another carbon led to the decrease of anticancer activity (i.e. 1,8-dihydroxyanthraquinone, 1,8-dihydroxy-3-methylanthraquinone or 1,3-dihydroxy-6-methoxy-8-methylanthraquinone). Hydroxyanthraquinones containing three hydroxy groups at different carbons showed their cytotoxicity IC 50 values more than 500.0 µM, (i.e., 1,4,7-trihydroxy-2-methoxy-6-methylanthraquinone and 1,3,8-trihydroxy-6-methylanthraquinone). It seems that multi-hydroxy-substitution was unfavorable to the cytotoxic activity . The compound 1-hydroxy-3-methylanthraquinone also induced apoptosis, probably related to mitochondrial dysfunction. Indeed, this compound did not intercalate into DNA according to a DNA binding assay and implied that apoptosis induced by this fungal monohydroxyanthraquinone might not involve DNA intercalation. The apoptosis rates of drug-treated cells with 12 [209], investigated the antimicrobial and antitumor activities of three benz[a]anthraquinone derivatives, i.e., brasiliquinones A, B, and C (isolated from the pathogenic strain Nocardia brasiliensis), against LI210, P388, and drug resistant P388/ADR tumor cells. The benz[a]anthraquinone derivatives brasiliquinones B and C were more effective against L1210 tumor cells than brasiliquinone A. The IC 50 values of the brasiliquinones B and C against L1210 and P388 tumor cells ranged from 2.9 to 7.0 µg/mL. The 3 compounds were active against Gram-positive bacteria including Mycobacterium sp.
The marine anthraquinone derivative, anhydrofusarubin isolated from the marine endophytic fungus Fusarium sp. No. b77, showed a significant inhibition of the growth of HEp2 and HepG2 cells, with IC 50 values of 8.67 and 3.47 µM, respectively [66,211].
In a recent review, Wang et al. [101] have summarized the sources and structures of 110 natural compounds including marine anthraquinone derivatives and other marine anthracene-9,10-diones mainly extracted from mangrove-derived fungi. They focused on their bioactivities reported between 2008 and mid-2013 and mentioned several moderate to significant anticancer activities.

Carcinogenic Effects
On the other hand, Ueno et al. [212] reported that the anthraquinone derivative rugulosin produced by fungi such as Penicillium rugulosum exhibited hepatocarcinogenic effects on male mice.
Moreover, the safety and effectiveness of emodin in naturopathic treatment have not been approved by the U.S. Food and Drug Administration (FDA). Side effects of emodin actually include potential carcinogenesis, nausea, diarrhea, and renal failure. Li et al. [213] reported that emodin showed no mutagenic activity in the Salmonella mutation assay, but caused genotoxicity in the thymidine kinase gene mutation assay in TK6 cells and in the micronucleus test. Results were in accordance with a previous study which indicated that emodin was genotoxic in several assays (comet assay, micronucleus test, and mutation assay in mouse lymphoma L5178Y tk`{´cells), whereas chrysophanol and physcion (two other anthraquinones often isolated from fungal cultures) showed no effects [214].
Two anthraquinone-type agents-danthron, a drug for constipation, and diacerein, an anti-inflammatory drug for osteoarthritis-were developed and approved by the U.S. FDA. However, danthron was withdrawn by the FDA in 1999 due to the risk of carcinogenesis. Therefore, clinical use of the naturally occurring anthraquinones should be considered cautiously [215].
Finally, all these findings clearly indicate that anthraquinone derivatives from marine and marine-derived fungi might be considered as potent sources of novel anticancer drugs and, at least, promising anti-leukemic agents, anti-invasive agents for human pancreatic and gastric cancers chemotherapy, and antitumor agents for hepatocellular carcinoma, bladder cancer, and others. However, the cytotoxicity caused by quinones is very complex and seems to occur through several mechanisms. Thus, due to differences in structures and characteristics among quinones, and to the dose-dependant responses observed, the molecular mechanism of the toxicity of each compound remains to be fully elucidated.

Special Focus on Protein Kinase Inhibition
The protein kinases are a large family of enzymes that transfer phosphate from adenosine triphosphate (ATP) to proteins as a means of regulating their activity and conformational state. The crucial role of protein kinases in cell signaling, gene expression, and metabolic regulation is highlighted by the fact that nowadays this family of enzymes is the second most important drug target. Actually, abnormal activity of individual protein kinases is often associated with human diseases, especially tumors whose treatment has been so far restricted to cytotoxic and hormonal agents. Many kinase inhibitors are currently in clinical trials, mostly as antitumor drugs, and two of them, Gleevec (STI-571) and rapamycin, are in clinical use for the treatment of a form of leukemia and for the prevention of tissue rejection after organ transplantation, respectively. One major problem with kinase inhibitors is that the human genome encodes 500 different protein kinases; therefore, inhibitors designed to target specifically an individual kinase are likely to bind to closely related kinases as well, thus interfering with other cell functions [216].
The interest of the scientific community has been also focused on the anthraquinone family as anthraquinones have been used for the purification of proteins by affinity techniques taking advantage of their nucleotide specific ligand capability. This enables them to interact with ATP, ADP, and NAD binding sites of enzymes such as dehydrogenases, kinases, and ATPases. A potential drawback of these compounds is that their cyclic planar structure confers them the feature of DNA-intercalators with expectable cytotoxic effects. Even with this limit, the optimization of highly specific and selective inhibitors of this category should be exploited [216].
Emodin is a biologically active natural compound extracted from the biomass of many marine or marine-derived fungi that can be chemically classified as an anthraquinone derivative (1,3,8-trihydroxy-6-methylanthraquinone). Several scientific studies have been performed that indicate the vast variety of effects mediated by this compound. Emodin is known to have anti-microbial, immunosuppressive, and anti-inflammatory activities. It exerts anti-proliferative effects in a vast array of cancer cell lines, often enhancing the sensitivity of cancer cells to chemotherapeutic drugs. The efficacy of emodin in inhibiting tumorigenesis is due, at least in part, to its ability to induce apoptosis [217].
Although the exact mechanism(s) of apoptosis induction by emodin remain unclear, several studies have indicated that this compound is an effective inhibitor of protein kinases that are known to regulate a wide range of cellular processes, including apoptosis. Emodin is a cell permeable inhibitor of protein kinase CK2, a constitutively active Ser/Thr kinase that is highly conserved and ubiquitously expressed in eukaryotic cells [217]. CK2 (an acronym derived from the misnomer "casein kinase 2") is probably the most pleiotropic protein kinase known with more than 300 protein substrates identified. At variance with the great majority of protein kinases which are normally inactive and are turned on only in response to specific stimuli, the enzyme is ubiquitously expressed in all eukaryotic cells. Abnormally high levels of CK2 have been observed in various types of cancer cells as compared to normal tissues, and CK2 is in fact invariably elevated in a wide variety of tumors [218]. Following this pharmaceutical hit with emodin, studies about anthraquinones were expanded with the addition of bromo (brominated anthraquinones exist in some marine fungal biomasses), nitro, amino or bromoacetamido groups, and many compounds were also active ( Table 3). Citreorosein (ω-hydroxyemodin) demonstrated similar kinase-inhibiting properties [219], and this kinase inhibiting action of anthraquinones was further linked to an anti-hypertensive potential as therapeutic agents [220]. Thereby, it would be very interesting to investigate the properties of the very large list of natural anthraquinones (over 100 compounds) produced by marine and marine-derived fungi, gathered for the first time in this review ( Table 2). Table 3. Effective anthraquinones with a protein kinase CK2 inhibitor activity (adapted from Meggio et al. [218]).

Name
Structure IC 50 (µM)-K i (µM) Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) The extreme manifestations of immunomodulating action of biologically active substances are immunosuppression and immunostimulation; hence, both immunostimulating agents and immunosuppressing agents have their own standing, and the search for better agents exerting these activities is becoming a field of major interest all over the world. Natural adjuvants, synthetic agents, and antibody reagents are used as immunosuppressive and immunostimulative agents. However, there are major limitations to the general use of these agents, such as increased risk of infection and generalized effect throughout the immune system. To overcome these problems, a number of drugs from natural source either plant or fungi have been used to alter the human immune system [221], with cyclosporine A, a fungal metabolite, being a successful immunosuppressive agent.
Among anthraquinones from marine-derived and non-marine-derived fungi, carviolin (roseo-purpurin), 1-O-methylemodin, and ω-hydroxy-emodin (citreorosein) were found to have moderate immunosuppressive activities. The immunosuppressive activities (IC50 values) of carviolin (roseo-purpurin), 1-O-methylemodin, and ω-hydroxyemodin (citreorosein) were calculated against concanavalin A-induced (T cell) and LPS (lipopolysaccharides)-induced (B cell) proliferation of mouse splenic lymphocytes [222]. The extreme manifestations of immunomodulating action of biologically active substances are immunosuppression and immunostimulation; hence, both immunostimulating agents and immunosuppressing agents have their own standing, and the search for better agents exerting these activities is becoming a field of major interest all over the world. Natural adjuvants, synthetic agents, and antibody reagents are used as immunosuppressive and immunostimulative agents. However, there are major limitations to the general use of these agents, such as increased risk of infection and generalized effect throughout the immune system. To overcome these problems, a number of drugs from natural source either plant or fungi have been used to alter the human immune system [221], with cyclosporine A, a fungal metabolite, being a successful immunosuppressive agent.

Immunomodulatory Activity
The term "immunomodulation" means the alteration of immune response which may increase or decrease. Enhancement in the immune responsiveness is called immunostimulation and reduction in the immune responsiveness is called immunosuppression. An immunomodulator may be defined as a substance, biological of synthetic, which can stimulate, suppress or modulate any of the components of the immune system including both innate and adaptive arms of the immune response [221]. The essence of immunomodulation is that a pharmacological agent acting under various dose and time regimens displays an immunomodulating effect.
The extreme manifestations of immunomodulating action of biologically active substances are immunosuppression and immunostimulation; hence, both immunostimulating agents and immunosuppressing agents have their own standing, and the search for better agents exerting these activities is becoming a field of major interest all over the world. Natural adjuvants, synthetic agents, and antibody reagents are used as immunosuppressive and immunostimulative agents. However, there are major limitations to the general use of these agents, such as increased risk of infection and generalized effect throughout the immune system. To overcome these problems, a number of drugs from natural source either plant or fungi have been used to alter the human immune system [221], with cyclosporine A, a fungal metabolite, being a successful immunosuppressive agent.

Antimicrobial Activities
The search for components with antimicrobial activity has gained increasing importance in recent times due to growing worldwide concern about the alarming increase in the rate of infection by antibiotic-resistant microorganisms. There has also been a rising interest in research for natural products from marine-microorganisms for the discovery of new antimicrobial agents in the last three decades [2,226]).
The two new hexahydroanthrones tetrahydrobostrycin and 1-deoxytetrahydrobostrycin isolated from the marine-derived fungus Aspergillus sp. strain 05F16 collected at a coral reef (Indonesia) demonstrated antibacterial activities. Tetrahydrobostrycin inhibited the growth of Staphylococcus aureus and Escherichia coli, at 100 mg/disc, with the inhibition zones of 15 and 9.2 mm in diameter, respectively. Another compound, 1-deoxytetrahydrobostrycin from the same strain, was active against S. aureus (12 mm at 100 mg/disc). The growth of Saccharomyces cerevisiae and Mucor hiemalis were not affected by these compounds at 100 mg/disc. It is interesting that the presence of an OH group at C-1 is important for the antibacterial activity of tetrahydrobostrycin against E. coli, although the antibacterial activities of these compounds are very weak [54].
Monodictyquinone A (1,8-dihydroxy-2-methoxy-6-methylanthraquinone) was produced from a culture of a marine-derived fungus of the genus Monodictys. Its antimicrobial activity was determined against Bacillus subtilis, Escherichia coli, and Candida albicans. This compound showed antibacterial activities against the three species with 2.5 µg/disk [82].
Catenarin and 1,4,6,8 tetrahydroxyanthraquinone, products of the Aspergillus glaucus group exhibited the highest antibacterial activity against exponentialy growing cells of Bacillus brevis. The concentration at 1 µg/mL of catenarin and tetrahydroxyanthraquinone resulted in a complete inhibition of the incorporation of uracil and leucine [36].
Isorhodoptilometrin-1-methyl ether was isolated from A. versicolor and exhibited antibacterial activity against the three Gram-positive bacterial strains Bacillus cereus, B. subtilis and S. aureus (inhibition zones 2, 3, and 5 mm at 50 µg/disk, respectively), and the C-6 propanol group is important for its activity, as determined by a comparison with inactive compound 1-methyl emodin [57].
As mentioned in Khamthong et al. 2012, anthraquinone-citrinin derivatives are rare natural products. Penicillanthranin A, an anthraquinone-citrinin derivative was isolated from the sea fan-derived fungus Penicillium citrinium PSU-F51. This molecule displayed a moderate antimicrobial activity against Staphylococcus aureus ATCC25923 with equal MIC values of 16 µg/mL. The same inhibitory effect was observed against S. aureus SK1 for penicillanthranin A, which was four fold more active than chrysophanol [88].
To date, most of the anthraquinones studied, isolated from various sources (plants, microbes) exhibited more antibacterial than antifungal activities.
The production of a virulence factor, essential for causing SSTIs (skin and soft tissue infections) by Staphylococcus aureus, is controlled by quorum sensing (QS), mediated by the accessory gene regulator (agr). From Daly et al. [227], ω-hydroxyemodin (OHM), a polyhydroxyanthraquinone isolated from solid-phase cultures of Penicillium restrictum, was identified as a suppressor of QS and a compound sought for the further characterization of the mechanism of action in mouse model. At concentrations that are nontoxic to eukaryotic cells and subinhibitory to bacterial growth, OHM prevented agr signaling by all four S. aureus agr alleles. OHM inhibited QS by direct binding to AgrA, the response regulator encoded by the agr operon, preventing the interaction of AgrA with the agr P2 promoter. Decreased dermonecrosis with OHM treatment was associated with enhanced bacterial clearance, and reductions in inflammatory cytokine transcription and expression at the site of infection. Furthermore, OHM treatment enhanced the immune cell killing of S. aureus in vitro in an agr-dependent manner. These data suggest that bacterial disarmament through the suppression of S. aureus QS may bolster the host innate immune response and limit inflammation.

Antiviral Activity
The search for compounds useful in combating viral infections has resulted in relatively few successes. Most of the clinically useful compounds discovered so far have been nucleoside analogues, the usefulness of which has often been limited by the development of toxic side effects and the emergence of drug-resistant viruses. Consequently, the discovery of new non-nucleoside compounds, which are less toxic to host cells and have different mechanisms of action than nucleoside analogues, would be of great value [228].
Some naturally occurring anthraquinones and their derivatives have been studied for antiviral activity against human immunodeficiency virus (HIV) and other retroviruses [229][230][231][232]. Some of these compounds have also been reported to possess in vitro antiviral activity against the herpes simplex viruses 1 and 2 (HSV-1, HSV-2), the influenza virus, the vesicular stomatitis virus [233], and the Epstein-Barr virus [234]. Murine Friend leukemia virus infections in mice have also been reported to be inhibited by polycyclic anthraquinone hypericin [235]. However, other investigators have seen no effect of hypericin on this virus infection in mice [232]. Other anthraquinones have been tested against HIV, but very few have been found to be active against this virus [231]. Tang et al. [232] have found that some anthraquinones also have virucidal activity against RNA and DNA viruses.
Alterporriol Q and tetrahydroaltersolanol C, isolated from the culture broth and mycelia of Alternaria sp. ZJ-2008003, which was collected from a soft coral (Sarcophyton sp.) from the South China Sea, expressed antiviral activity against the porcine reproductive virus and respiratory syndrome virus, with IC50 values of 39 and 65 µM, respectively [48].
Alizarin, emodin, emodin anthrone, emodin bianthrone, but also other anthraquinones such as quinalizarin, rhein, hypericin, and protohypericin, showed activity against HCMV strain AD-169 (human cytomegalovirus), distinguishable from cytotoxic effects on cells. Of these, quinalizarin had the highest therapeutic index at 3.4, and emodin anthrone and emodin bianthrone the lowest, probably due to their low solubility indices. The EC 50 values (effective concentrations giving half-maximal response) of alizarin, quinalizarin, and rhein were lower in experiments with the ganciclovir-resistant strain than with the AD-169 virus strain [236].
Aloe-emodin showed the strongest inhibition of virus yield among emodin and chrysophanol towards MDCK cells. Aloe-emodin treatment caused more than 1-log reduction (equal to 90% effective concentration [EC90]) in virus RNA loads. Subsequent plaque assay determined half maximal inhibitory concentration (IC50) value of aloe-emodin on virus yield. Aloe-emodin showed dose-dependent inhibition of virus-induced cytopathic effect. Infected cells showed about 50% cytopathic effect, those treated with aloe-emodin at concentrations of 1 and 2.5 µg/mL were less than 10% [237].

Other Identified Biological Activities
In a review published in 2015, Chien et al. [215] outlined the chemical structure and biological properties of the naturally occurring anthraquinones and their derivatives with an emphasis on recent findings about their therapeutic potential in autoimmune diabetes. So far, 79 naturally occurring anthraquinones have been highlighted, which include emodin, physcion, cascarin, catenarin, and rhein. A large body of literature has demonstrated that the naturally occurring anthraquinones possess a broad spectrum of bioactivities, such as anticancer, antimicrobial, antiinflammatory, but also cathartic, diuretic, vasorelaxing, and phytoestrogenic. This suggests their possible clinical application in many diseases. Despite the advances that have been made in understanding the chemistry and biology of the anthraquinones in recent years, research into their mechanisms of action and therapeutic potential in autoimmune disorders is still at an early stage [244][245][246][247][248][249][250].

Antioxidant Activities
Oxidative stress contributes to free radical-mediated diseases such as aging, atherosclerosis, cancer, ischemic heart disease, diabetes, hyperlipidaemia, hepatotoxicity, and neurodegenerative diseases. There is considerable interest in the isolation of potent radical scavenging compounds from natural resources to treat these pathologies. Natural and synthetic anthraquinones and their derivatives clearly demonstrated their antioxidants potential [63,246,[251][252][253][254].
3-O-(α-D-Ribofuranosyl)-questin was isolated and identified in Eurotium rubrum, an endophytic fungal strain that was isolated from the inner tissue of the stem of the marine mangrove plant Hibiscus tiliaceus. The compound was evaluated for its radical scavenging activities by using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay and showed weak-moderate activity [63].
From Nemeikaite-Ceniene et al. [255] there is a correlation between the cytotoxicity of natural hydroxyanthraquinones (e.g., emodin and chrysophanol) or model quinones on FLK cells (bovine leukemia virus transformed lamb kidney) and HL-60 cells (human promyelocytic leukemia), and the redox cycling reactions inducing the formation of superoxide. This ability can then be determined by the E1 7values (values of single-electron reduction midpoint potential at pH 7.0). They concluded that the rate constants of the single-electron enzymatic reduction of natural hydroxyanthraquinones may serve as a useful tool for the quantitative description of their cytotoxity with the involvement of oxidative stress.

Diuretic Activity
The diuretic action of emodin and aloe-emodin is probably due to their strong competitive inhibition on Na + -K + -ATPase activity. From a study of Zhou et al. [247], these compounds demonstrated IC 50 values of 9.8 µg/mL and 19.3 µg/mL and Ki values of 1.33ˆ10´6 and 7.41ˆ10´6, respectively.

Laxative Activity
Anthranoid laxatives of natural origin, mainly extracted from plants are widely used [256,257]. The basic structure for all anthranoid laxatives is an anthracene ring, to which a hydroxyl or carbonyl function is substitued at C-9, and hydroxy groups at C-8.
Aloe-emodin and chrysophanol are among the most common anthraquinone laxatives [258]. Emodin also forms the basis of a range of purgative anthraquinone derivatives and, from ancient times, has been widely used as a laxative compound. It is believed that the presence of hydroxyl groups in position 1 and 8 of the aromatic ring system is essential for the purgative action of the compound [259].
Because of its chemical structure, emodin glycosides (and other anthraquinones) are carried unabsorbed to the large intestine in mammals, where metabolism to the active aglycones takes place by intestinal bacterial flora. The aglycone exerts its laxative effect by damaging epithelial cells, which leads directly and indirectly to changes in absorption, secretion and motility [258,260]. Emodin also inhibits the ion transport (Cl´-channels) across colon cells, contributing to the laxative effect [249,261].
There is good evidence that anthrones/anthraquinones, known as active metabolites of emodin-type O-and C-glycosyl compounds, influence the ion transport across colon cells, although the target transport systems have not yet been elucidated. To solve the problem of contradictory explanations about the laxative action of these drugs, a study tested 25 different anthrone/anthraquinone metabolites of plant drugs. Their influence was assayed on different ion transport systems in Ehrlich cells as a model system. Comparing the laxative potency of these substances, with their influence on the different ion transport systems involved in trans-epithelial ion transport, made it possible to exclude some transport processes as primary targets of the drugs. The results showed that Na + -K + -2Cl-cotransport was not inhibited by any of the substances tested and that Na + /K + -ATPase (pump) was inhibited by those 1,8-dihydroxyanthrones/anthraquinones that bear an additional phenolic hydroxyl group. This inhibition is indirect by interference with oxidative ATP production. However, there is no direct correlation to laxative action. In addition, cation channels were not influenced by these drugs, and Cl´-channels were inhibited significantly by those drugs that also showed a laxative action. These results make it very likely that inhibition of Cl´-channels is the primary action responsible for the laxative action. Interference with oxidative ATP production as an additional effect may explain the known synergistic action described for the combination of different anthrones/anthraquinones or anthranoid drugs, respectively [261].
In addition, 1,3,6,8-trihydroxymethylanthraquinone was used in a patented laxative preparation for intravascular injection, active by stimulating the neuromuscular junction of the bowel wall [262].
Studies in humans have also suggested tumor promoting activities for these laxatives. Although the short-term use of these substances is generally safe, long-term utilization cannot be recommended.

Vasorelaxant or Contractile Effects
In a first study of Huang et al. [263], the vasorelaxant effect of emodin was assayed as the ability to relax rat thoracic aortic rings precontracted with phenylephrine. The vasorelaxant activity of emodin was expressed as a percentage of relaxation of the maximal tension increase produced by phenylephrine. The concentration evoking 50% relaxation (IC 50 value) showed that emodin exhibits vasorelaxant effect, and dose-dependently relaxed the contractile responses of rat aortic rings. In the same study, emodin also dose-dependently suppressed the responses of human mononuclear cells to phytohemagglutininand mixed lymphocytereaction. Thus, this compound may be useful as a new template for the development of better immunosuppressive agents, with vasorelaxant actions useful against transplantation rejection and autoimmune disease.
The possible mechanism underlying the vasorelaxant effect of emodin was investigated in a second study by Huang et al. [264]. Emodin dose-dependently relaxed isolated vascular rings of several vessels in animals and human, in case of induced contraction. The study also investigated the inhibition, attenuation, or potentiation of relaxation response to emodin by various compounds. It suggested that the vasorelaxant effect of emodin might be mainly due to cGMP accumulation, as a result of guanylate cyclase activation by free radicals and/or hydrogen peroxide generated from semiquinone.
The effects of emodin on skeletal muscle were studied in a mouse-isolated diaphragm and in sarcoplasmic reticulum (SR) membrane vesicles [265]. Emodin dose-dependently caused muscle contracture, simultaneously depressing twitch amplitude. Neither tubocurarine nor tetrodotoxin (neuromuscular non-depolarizing agents) blocked the contraction, suggesting that it was caused myogenically. These data suggest that muscle contraction induced by emodin is dose-dependent and is due to Ca 2+ release from the SR of skeletal muscle, as a result of oxidation of the ryanodine receptor and influx of extracellular Ca 2+ through voltage-dependent Ca 2+ channels of the plasma membrane.

Effects on Lipid and Glucose Metabolism
Several drawbacks of many pharmaceutic drugs used for the treatment of Diabetes mellitus have contributed to the use of "natural" products. Emodin, which was extensively studied, has anti-inflammatory, analgesic [266], and antipancreatitic [267] effects. Its anti-diabetic activity was investigated by evaluating its hypoglycaemic and hypolipidaemic effects, together with its potential effects on L-type calcium-channels in dyslipidaemic-diabetic rats. The results demonstrated significant dose-dependent reductions in blood glucose, serum total cholesterol, triglycerides, free fatty acids, and malonaldehyde in dyslipidaemic-diabetic rats. In addition, emodin caused dose-dependent increases in their plasma superoxide dismutase activity. The results suggest that emodin has antidiabetic and lipid-modulating effects that involve, in part, upregulation of L-type calcium channel expression in the pancreas and heart of dyslipidaemic-diabetic rats [268].
The antidyslipidemic effect of several anthraquinone derivatives as chrysophanol and emodin obtained from Rheum emodi 1 s rhizomes was evaluated. These compounds significantly reduced plasma lipid levels. The most active compound emodin showed significant lipid-lowering activity in the HFD-fed model. The effect of emodin on enzymes modulating lipid metabolism confirms and supports its efficiency as a potent antidyslipidemic agent [269].

Estrogenic Activity
Insufficiency of endogenous estrogen secretion is known to cause several physical disorders in postmenopausal women, such as osteoporosis, hypercholesteremia, and symptoms of menopause. Synthetic estrogen-replacement therapy has been reported to be effective for these diseases. Recently, the estroenic activity of phytoestrogens was reported. A study of these compounds, which are distributed in vegetables, fruits, and medicinal plants, evaluated the estrogenic activity of the methanolic extracts from several medicinal herbs. The study was guided by the detection of a proliferative activity of MCF-7,1 (estrogen-sensitive cell line) [244]. A bioassay-guided separation led to emodin, which enhanced proliferation of MCF-7 from 1 to 10 mM in a concentration-dependent manner. Aloe-emodin and chrysophanol showed weak activity. By comparison of the activities, the 6-hydroxyl group seemed to be essential for enhancement of the estrogenic activity.
To clarify the affinity of the active anthraquinones to human estrogen receptors ERα and Erβ, a competitive binding assay was performed using 17β-estradiol. Aloe-emodin and chrysophanol did not compete with ERα and ERβ for 17β-estradiol binding at a high concentration (40mM). Conversely, emodin competed for 17β-estradiol binding with both ERα and ERβ.
Concerning the structure-activity relationships of anthraquinones regarding the oestrogenic activity, it is quite clear that the unchelated hydroxyl group is essential for a strong estrogenic competency. This is the first report for estrogenic activity of anthraquinones. The findings that emodin bonds with human ERα and ERβ may be useful for replacement therapy for human menoxenia and post-menopausal diseases.

Conclusions
The recent developments in technology helped in promoting the increased use of natural molecules in industries. Thereby, the microorganisms naturally producing bioactive or useful extrolites recently appeared as a great source of potentially interesting molecules. Opposite to plants and insects, these easily renewable and upscalable resources (short production cycles), independent of seasonality, can give regular productions with potentially higher yields. Unfortunately, far more than the chemical synthetic routes, the biological synthesis requires a deep comprehension of the phenomena involved, and often implies very thin adjustments. This is one of the reasons why some have expressed doubts about the successful production and commercialization of fermentation-derived compounds. Others dealt with the high capital investment requirements for fermentation facilities and the extensive and lengthy toxicity studies required by regulatory agencies. However, several microbial genera are capable of producing highly original compounds in large quantities, and could meet the economic needs of companies, if we are ready to embark on the challenges of the production of natural molecules through biotechnology. For now, the question is: Can the recent and future research efforts on the fungal strains, the productions 1 methods, and the biosynthetic improvments reveal secure ways to produce targeted molecules? Thus, it seems that anthraquinoid compounds produced by fungi are quite new tracks for research and applications.